{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-107566","form_type":"8-K","ticker":"XXII","cik":"0001347858","company_name":"22nd Century Group, Inc.","filed_at":"2021-08-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.792250+00:00","generated_at":"2026-06-29T08:52:39.729683+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"22nd Century Group appoints Anthony Johnson to Board of Directors","bullets":["Anthony Johnson appointed as Class II director effective August 18, 2021.","Johnson is co-founder, President, CEO of Kodikaz Therapeutic Solutions and founding partner of Buffalo Biosciences.","Will serve on Scientific, Finance and Compensation Committees; receives standard non-employee director compensation.","Bring experience in biotechnology, genomics, and life sciences; held roles at Empire Genomics and Thermo Fisher."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-107566","json":"https://secwatch.observer/filing/0001104659-21-107566.json","markdown":"https://secwatch.observer/filing/0001104659-21-107566.md","text":"https://secwatch.observer/filing/0001104659-21-107566.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347858/000110465921107566/0001104659-21-107566-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347858/000110465921107566/tm2125456d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T08:52:39.729683+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9b17398d69","claim":"Anthony Johnson was appointed as Director at 22nd Century Group, Inc..","evidence_excerpt":"appointed Anthony Johnson, to be a director on the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1347858/000110465921107566/0001104659-21-107566-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}